Product Information
ANGELIQ 0.25 MG-0.5 MG TABLET is a brand product labeled by Bayer HealthCare Pharmaceuticals Inc., priced at $6.3727 per EA under NDC 50419048203. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
.25; .5 mg/1; mg/1
Manufacturer
Bayer HealthCare Pharmaceuticals Inc.NDC
50419048203
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DROSPIRENONE; ESTRADIOLApproval Type
New Drug (NDA)
FDA Application
NDA021355On Market Since
2/29/2012
Price Statistics
The NADAC for ANGELIQ 0.25 MG-0.5 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3727 per EA |
|---|---|
| All-time high | $6.4094 (May 14, 2025) |
| All-time low | $6.3441 (Nov 19, 2025) |
| 52-week high | $6.3788 |
| 52-week low | $6.3441 |
| Median price | $6.3770 |
| Average price | $6.3803 |
| Largest weekly change | -0.6% (May 21, 2025) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the drospirenone and estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ANGELIQ 0.25 MG-0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ANGELIQ 0.25 MG-0.5 MG TABLET, manufactured by Bayer HealthCare Pharmaceuticals Inc., is $6.3727 per EA (NDC 50419048203), effective Jun 24, 2026.
How has the price of ANGELIQ 0.25 MG-0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ANGELIQ 0.25 MG-0.5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ANGELIQ 0.25 MG-0.5 MG TABLET?
Since Apr 17, 2024, the NADAC for ANGELIQ 0.25 MG-0.5 MG TABLET has ranged from a low of $6.3441 (Nov 19, 2025) to a high of $6.4094 (May 14, 2025), with a median of $6.3770 per EA.
Are there cheaper alternatives to ANGELIQ 0.25 MG-0.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ANGELIQ 0.25 MG-0.5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ANGELIQ 0.25 MG-0.5 MG TABLET?
ANGELIQ 0.25 MG-0.5 MG TABLET (NDC 50419048203) is labeled by Bayer HealthCare Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification